Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD. - Gregg LP; Bozkurt B; Navaneethan SD (Clinical journal of the American Society of Nephrology : CJASN, 2025)